Dentists in Tahoe City, CA Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Jack Semmens, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 495 North Lake Blvd - 96145, Ste 270, Tahoe City, CA 96145 Phone: 530-583-5546 Fax: 530-583-3559 |
Darin Michael Delgado, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3080 North Lake Blvd, Suite 301, Tahoe City, CA 96145 Phone: 530-583-2349 |
Richard R Tomlinson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 140 Mackinaw Road, Tahoe City, CA 96145 Phone: 530-583-0278 Fax: 530-583-8660 |
Dr. Jon Hugh Dickson, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 605 West Lake Blvd., Suite 1, Tahoe City, CA 96145 Phone: 530-583-2349 Fax: 530-583-6745 |
Dr. Robert Edward Claman, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 925 North Lake Blvd, Suite B-206, Tahoe City, CA 96145 Phone: 530-583-4276 Fax: 530-583-6637 |
News Archive
Bio-Bridge Science receives business license for Bio-Bridge JRS Biosciences (Beijing)
Bio-Bridge Science, Inc., a biotechnology company engaged in the commercial development of vaccines and vaccine-related products announced today that the Company received a business license from the Beijing Administration for Industry and Commerce of the People's Republic of China ("PRC") indicating approval of the formation of Bio-Bridge JRS Biosciences (Beijing) Co., Ltd. ("Bio-Bridge JRS").
UB transgenic mouse model of Timothy Syndrome improves understanding of autism
The first transgenic mouse model of a rare and severe type of autism called Timothy Syndrome is improving the scientific understanding of autism spectrum disorder in general and may help researchers design more targeted interventions and treatments.
Department of Veterans Affairs awards $25M task order to Leidos
Leidos, a national security, health and engineering solutions company, was awarded a task order by the Department of Veterans Affairs (VA) to provide technical and programmatic support to assist the VA in executing the OneVA Enterprise Architecture (EA) program.
Gene alterations associated with response to anthracycline therapy for breast cancer
Alterations in the topoisomerase II alpha (TOP2A) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based regimens, according to a study in the April 28 online issue of the Journal of the National Cancer Institute.
› Verified 5 days ago